Hello, Thanks for signing up for MarketBeat Daily Ratings—we’re excited to have you on board. Every weekday, you’ll get a curated summary of new “Buy” and “Sell” ratings from Wall Street’s top-rated analysts, the latest stock news, and bonus investing content—all delivered straight to your inbox. You’re just two quick steps away from completing your sign-up: 1. Make sure our emails go to your inboxGmail users:
Mobile: Tap the three dots (…) in the top right and select Move to Inbox or Move to Primary
Desktop: Click the folder icon at the top and select Move to Inbox or Primary Apple Mail users:
Tap our email address at the top (next to From: on mobile), then select Add to VIP Other providers:
Reply to this message and add newsletters@analystratings.net to your contacts 2. Confirm your subscriptionClick this link to confirm your subscription. This verifies your account and ensures you receive your newsletters without interruption instead of getting stuck in your spam filter. Confirm your subscription here. After you confirm, feel free to download our popular free report, "7 Stocks to Buy and Hold Forever" with this link. Thanks again for subscribing—we look forward to being part of your investing journey. 
Matthew Paulson
Founder and CEO, MarketBeat. P.S. If you didn’t mean to subscribe, no problem—you can unsubscribe here.
Wednesday's Featured Content
3 Oversold Healthcare Stocks to Buy After Jobs DataReported by Chris Markoch. Date Posted: 4/13/2026. 
Key Points
- Strong March job growth in healthcare is reinforcing the sector’s defensive appeal, creating opportunities to buy high-quality stocks after recent pullbacks.
- HCA Healthcare and Tenet Healthcare stand out for their scale, earnings strength, and institutional support, with both stocks rebounding from oversold levels.
- Universal Health Services offers turnaround potential and added upside from its Talkspace acquisition, positioning it for recovery as sentiment improves.
- Special Report: Elon Musk: This Could Turn $100 into $100,000
The March jobs report, released April 3, showed 178,000 jobs were created, including 76,000 in the healthcare sector — a reversal from the prior quarter's decline. Most of those gains were in hospitals and ambulatory care services. For investors, the report reinforces the case for select stocks in the space, particularly for those seeking defensive names that offer both safety and modest growth.
Millionaire Trader Exposes: "The Single Stock Income Plan"
With over 6,000 stocks on the market to choose from...
Millionaire trader Nate Bear IGNORES 99% of them...
Instead, he trades just one...
He calls it: "The Single Stock Income Plan".
And in a single month, while the S&P 500 handed investors a measly 0.05% return...
His readers had the chance to collect: 100% in the same day... 100% overnight... 100% in 3 days... and 114% in 3 days.
Four separate trades. One stock. And all could've DOUBLED your money.
That's the equivalent of collecting 40 YEARS of typical stock market gains... crammed into a single month. Click here for details
That’s a tricky combination, but one the healthcare sector is uniquely equipped to deliver, thanks to an aging population and steady utilization of services. Those dynamics can create opportunities when strong companies pull back. This article highlights three such names. Each has a mix of operational strength, earnings power, and attractive valuation, and each benefits from ongoing demand for medical care even when the labor backdrop is uneven. HCA Healthcare: A Scaled Leader With Defensive AppealHCA Healthcare (NYSE: HCA) owns and operates a network of hospitals and related healthcare facilities, including acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's scale gives it leverage in staffing, purchasing, and hospital operations, which helps offset cost pressure. HCA hit oversold levels in late March, then rallied after the jobs report to trade near its 50-day simple moving average (SMA). It has since pulled back slightly; a consensus price target of $537.73 indicates healthy upside. 
Analysts have been raising price targets after the company’s strong earnings report, in which HCA beat on both the top and bottom lines and issued constructive full-year guidance. For investors seeking a steadier healthcare rebound, HCA has one of the cleanest profiles in the sector. It combines defensive demand, operating efficiency, and a long track record of execution. At around 17X earnings, it trades at a slight premium to the sector average, but it remains a compelling buy on pullbacks. Tenet Healthcare: Momentum and Institutional Support Stand OutTenet Healthcare Corp. (NYSE: THC) is a competitor of HCA and, like HCA, has shown strong growth over the past year, climbing more than 50% on the back of robust revenue and earnings gains. Not surprisingly, THC's chart resembles HCA's. The stock touched oversold levels in late March but has climbed since the jobs report, bouncing off a level that acted as prior support in January. 
Tenet is widely viewed as a sector leader, supported by institutional ownership of over 95%. Institutional buying outpaces selling by nearly 2:1 and has been consistent over the past four quarters. Analysts remain bullish. Even after a 7.4% rally in the five trading days ending April 9, the stock sits roughly 30% below its consensus price target of $250.56. Universal Health Services: A Turnaround With Digital UpsideUniversal Health Services (NYSE: UHS) is another diversified healthcare management company operating a portfolio similar to Tenet and HCA. It has a unique catalyst: the company announced an agreement to acquire Talkspace (NASDAQ: TALK), which would give UHS a significant foothold in digital mental health. UHS is down about 17% in 2026, partly due to an earnings miss on both the top and bottom lines that reversed a rally which began in late January. Like the other names here, UHS bounced off oversold levels in late March and is attempting to recover. 
Analysts are constructive, assigning UHS a consensus price target of $232.21 — roughly 30% upside. The stock also has strong institutional backing, with about 86% institutional ownership, and buying has consistently outpaced selling over the last four quarters. |
0 Response to "We're excited to have you on board"
Post a Comment